Mathias Schmidt
Impact in
- Oncology top 2%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cell Biology top 5%
- Microtubule and mitosis dynamics
Papers in
-
- Cell death mechanisms and regulation 5
- PI3K/AKT/mTOR signaling in cancer 4
- Immunology 19
- Toxin Mechanisms and Immunotoxins 15
- Co-authors
- Holger Bastians (1 shared paper)Winfried S. Wels (16 shared papers)Zhen Fan (6 shared papers)Bolin Liu (5 shared papers)John Mendelsohn (3 shared papers)Yang Lü (3 shared papers)Volker Gekeler (6 shared papers)Manfred Dietel (4 shared papers)
- Journals
- Nuklearmedizin - NuclearMedicine (7 papers)International Journal of Cancer (5 papers)British Journal of Cancer (5 papers)Oncogene (4 papers)Blood (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Mathias Schmidt
60 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 91
- Oncology 925
- Cell Biology 429
- Cancer Research 237
- Molecular Biology 1.1k
- Genetics 133
Countries citing papers authored by Mathias Schmidt
This map shows the geographic impact of Mathias Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Schmidt more than expected).
Fields of papers citing papers by Mathias Schmidt
This network shows the impact of papers produced by Mathias Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Schmidt. The network helps show where Mathias Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Mathias Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 390 | |
| 2 | 2004 | 160 | |
| 3 | 2007 | 152 | |
| 4 | 2004 | 150 | |
| 5 | 2005 | 127 | |
| 6 | 2000 | 115 | |
| 7 | Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy. | 2003 | 103 |
| 8 | 2000 | 90 | |
| 9 | 2014 | 90 | |
| 10 | 2000 | 63 | |
| 11 | 2000 | 58 | |
| 12 | 1999 | 52 | |
| 13 | 2004 | 49 | |
| 14 | Systemic treatment with a recombinant erbB-2 receptor-specific tumor toxin efficiently reduces pulmonary metastases in mice injected with genetically modified carcinoma cells. | 1998 | 45 |
| 15 | 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors. | 2002 | 44 |
| 16 | 2006 | 42 | |
| 17 | 2002 | 41 | |
| 18 | 2002 | 39 | |
| 19 | 1996 | 36 | |
| 20 | 2001 | 35 |
About Mathias Schmidt
Mathias Schmidt is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 61 papers that have together received 2.3k indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (15 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Microtubule and mitosis dynamics (10 papers), Cancer-related Molecular Pathways (10 papers), Thyroid Cancer Diagnosis and Treatment (8 papers), Cell death mechanisms and regulation (5 papers), HER2/EGFR in Cancer Research (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). The work is most often cited by research in Oncology (925 citations), Cell Biology (429 citations), Cancer Research (237 citations), Molecular Biology (1.1k citations) and Genetics (133 citations). Mathias Schmidt has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Holger Bastians, Winfried S. Wels, Zhen Fan, Bolin Liu, John Mendelsohn, Yang Lü, Volker Gekeler, Manfred Dietel, Carsten Denkert and Wilko Weichert. Their work appears in journals such as Nuklearmedizin - NuclearMedicine, International Journal of Cancer, British Journal of Cancer, Oncogene and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.